Of note, impaired tumour formation in the two‐stage skin carcinogenesis model, where TPA treatment activates AP1 TF complexes, does indeed suggest AP1‐YAP/TAZ/TEAD cooperation in driving cSCC development.12 This evidence concerns the gene JUN and neoplasm.